We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email :PharmaSources@imsinoexpo.com
Whatsapp :+86-13621645194
Citicoline sodium injection is a sterile solution containing citicoline sodium, a compound that serves as a precursor to both choline and cytidine. Citicoline is known for its role in supporting brain function, memory, and cognitive performance.
Indications:
Citicoline sodium injection may be indicated for: Cognitive Enhancement: Citicoline has been studied for its potential to improve cognitive function, memory, and attention in individuals with cognitive impairment or neurological disorders. Neuroprotection: Citicoline exhibits neuroprotective properties, potentially aiding in the preservation of brain tissue and function following injury or ischemic events such as stroke. Treatment of Neurological Disorders: Citicoline sodium injection may be used as adjunctive therapy in the management of certain neurological conditions, including stroke, traumatic brain injury, and neurodegenerative diseases.
Administration:
Citicoline sodium injection is typically administered intravenously under the supervision of a healthcare professional. The dosage and administration regimen may vary depending on the patient's condition, medical history, and the judgment of the prescribing physician.
Safety and Considerations:
As with any medication, citicoline sodium injection should be used with caution and under the guidance of a qualified healthcare provider. Special consideration should be given to patients with renal impairment, hepatic dysfunction, or other underlying medical conditions affecting drug metabolism.